We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+10.37%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$6.31B
AUM Growth
+$553M
Cap. Flow
+$7.17M
Cap. Flow %
0.11%
Top 10 Hldgs %
38.54%
Holding
691
New
7
Increased
60
Reduced
171
Closed
20

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$21M
2
CRM icon
Salesforce
CRM
+$15.4M
3
BDX icon
Becton Dickinson
BDX
+$15.3M
4
AMT icon
American Tower
AMT
+$9.87M
5
HDB icon
HDFC Bank
HDB
+$9.45M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.8M
2
RTX icon
RTX Corp
RTX
+$9.58M
3
CL icon
Colgate-Palmolive
CL
+$8.83M
4
AYI icon
Acuity Brands
AYI
+$6.25M
5
SBUX icon
Starbucks
SBUX
+$5.95M

Sector Composition

Rank Sector Weight
1 Technology 30.1%
2 Healthcare 18.05%
3 Financials 10.56%
4 Consumer Discretionary 9.68%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HII icon
426
Huntington Ingalls Industries
HII
$12.8B
$49K ﹤0.01%
190
FMS icon
427
Fresenius Medical Care
FMS
$12.6B
$48K ﹤0.01%
926
GSK icon
428
GSK
GSK
$101B
$48K ﹤0.01%
960
-200
-17% -$10.2K
MSEX icon
429
Middlesex Water
MSEX
$1.11B
$48K ﹤0.01%
1,000
EWJ icon
430
iShares MSCI Japan ETF
EWJ
$23.2B
$47K ﹤0.01%
773
LVS icon
431
Las Vegas Sands
LVS
$29.6B
$47K ﹤0.01%
800
RIG icon
432
Transocean
RIG
$6.39B
$47K ﹤0.01%
3,404
FBRX icon
433
Forte Biosciences
FBRX
$1.57B
$45K ﹤0.01%
8
STZ icon
434
Constellation Brands
STZ
$23.1B
$45K ﹤0.01%
209
JEF icon
435
Jefferies Financial Group
JEF
$12.6B
$44K ﹤0.01%
2,262
BWA icon
436
BorgWarner
BWA
$14B
$43K ﹤0.01%
1,136
ITUB icon
437
Itaú Unibanco
ITUB
$81.1B
$42K ﹤0.01%
7,797
ESRX
438
DELISTED
Express Scripts Holding Company
ESRX
$42K ﹤0.01%
440
BNY
439
Bank of New York Mellon
BNY
$109B
$41K ﹤0.01%
800
KBWB icon
440
Invesco KBW Bank ETF
KBWB
$6.83B
$41K ﹤0.01%
750
KHC icon
441
Kraft Heinz
KHC
$29.7B
$40K ﹤0.01%
722
VYGR icon
442
Voyager Therapeutics
VYGR
$198M
$40K ﹤0.01%
2,100
WBK
443
DELISTED
Westpac Banking Corporation
WBK
$40K ﹤0.01%
2,000
+1,000
+100% +$21.1K
AME icon
444
Ametek
AME
$58.7B
$39K ﹤0.01%
498
AZN icon
445
AstraZeneca
AZN
$245B
$39K ﹤0.01%
499
SGEN
446
DELISTED
Seagen Inc. Common Stock
SGEN
$39K ﹤0.01%
505
DVN icon
447
Devon Energy
DVN
$48.7B
$38K ﹤0.01%
942
MUR icon
448
Murphy Oil
MUR
$4.99B
$38K ﹤0.01%
1,125
JHI
449
John Hancock Investors Trust
JHI
$117M
$37K ﹤0.01%
2,316
A icon
450
Agilent Technologies
A
$42.1B
$36K ﹤0.01%
514

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 691 positions worth $6.31B, up 9.6% from $5.76B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.9%. Loring Wolcott & Coolidge Fiduciary Advisors opened 7 new positions and exited 20, leaving the 691-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2018 buy was Vanguard FTSE Developed Markets ETF: 16,287 shares worth $705K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NXP Semiconductors in Q3 2018, an estimated $21M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $10.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco FTSE International Low Beta Equal Weight ETF in Q3 2018, selling an estimated $910K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 39% of its $6.31B portfolio in Q3 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 7 new positions and closed 20 in Q3 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 9.6% quarter-over-quarter to $6.31B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2018, filed 31 Oct 2018.